Integration of the Hamilton Microlab Star within HtL at AstraZeneca R&D Charnwood
News Jun 06, 2007
AstraZeneca requires automation of multiple applications across different processes. The use of the flexible and modular Microlab® Star enables AstraZeneca to use one instrument for diverse applications ranging from compound dilution to assay construction.
Working closely with AstraZeneca, Hamilton have designed a system that has greater capacity and functionality than AstraZeneca’s previous machines, enabling them to carry out accurate dilutions.
The Microlab STAR’s features like “Dual Liquid Level Detection”, “Monitored Air Dipslacement” and the CO-RE technology have increased the process safety remarkably at AstraZeneca.
The Hamilton Software has been incorporated into the in-house sample management system, which has enabled full sample/data tracking and an increase in the speed of sample processing.
The Microlab STAR system shows a decrease in assay variability and an increase in throughput and accuracy. As a result the Microlab STAR has become the benchmark instrument within HtL at AstraZeneca R&D Charnwood.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential DrugsNews
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles.READ MORE
Comments | 0 ADD COMMENT
Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 21 - May 22, 2018